About 13.3 million people applied for Covid-19 vaccinations in India on Thursday, the first day the vaccine was made available to everyone between the ages 18 and 44, according to the government's dedicated vaccination website, CoWIN.
India is administering two vaccines domestically: the Oxford-AstraZeneca shot, also known as Covishield, and its homegrown Covaxin, developed jointly by Bharat Biotech and the government-run Indian Council of Medical Research (ICMR).
CoWIN opened for registrations on Wednesday. As of Thursday at 12 p.m. local time, a further 4.15 million have registered to receive vaccinations.
India kickstarted its vaccination program in January for health care workers and priority groups, hoping to fully inoculate 300 million people by August. The start was sluggish due to logistical issues and vaccine hesitancy among the population – especially toward Covaxin, which was approved for emergency use before the efficacy data of its third phase trial were released.
As of Wednesday evening local time, 150,020,648 vaccine doses had been administered in India